324 related articles for article (PubMed ID: 26299750)
1. Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles.
Kumar R; Ray PC; Datta D; Bansal GP; Angov E; Kumar N
Vaccine; 2015 Sep; 33(39):5064-71. PubMed ID: 26299750
[TBL] [Abstract][Full Text] [Related]
2. A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.
Jones RM; Chichester JA; Manceva S; Gibbs SK; Musiychuk K; Shamloul M; Norikane J; Streatfield SJ; van de Vegte-Bolmer M; Roeffen W; Sauerwein RW; Yusibov V
Hum Vaccin Immunother; 2015; 11(1):124-32. PubMed ID: 25483525
[TBL] [Abstract][Full Text] [Related]
3. Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.
Patra KP; Li F; Carter D; Gregory JA; Baga S; Reed SG; Mayfield SP; Vinetz JM
Infect Immun; 2015 May; 83(5):1799-808. PubMed ID: 25690099
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.
Lee SM; Wu CK; Plieskatt J; McAdams DH; Miura K; Ockenhouse C; King CR
Malar J; 2016 Aug; 15(1):405. PubMed ID: 27515826
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
Chichester JA; Green BJ; Jones RM; Shoji Y; Miura K; Long CA; Lee CK; Ockenhouse CF; Morin MJ; Streatfield SJ; Yusibov V
Vaccine; 2018 Sep; 36(39):5865-5871. PubMed ID: 30126674
[TBL] [Abstract][Full Text] [Related]
7. Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.
Kumar R; Angov E; Kumar N
Infect Immun; 2014 Apr; 82(4):1453-9. PubMed ID: 24421036
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant
Parzych EM; Miura K; Ramanathan A; Long CA; Burns JM
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28993460
[TBL] [Abstract][Full Text] [Related]
9. Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
Li Y; Leneghan DB; Miura K; Nikolaeva D; Brian IJ; Dicks MD; Fyfe AJ; Zakutansky SE; de Cassan S; Long CA; Draper SJ; Hill AV; Hill F; Biswas S
Sci Rep; 2016 Jan; 6():18848. PubMed ID: 26743316
[TBL] [Abstract][Full Text] [Related]
10. Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.
Datta D; Bansal GP; Grasperge B; Martin DS; Philipp M; Gerloff D; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2017 Dec; 35(50):7049-7056. PubMed ID: 29132995
[TBL] [Abstract][Full Text] [Related]
11. Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles.
Kumar R; Ledet G; Graves R; Datta D; Robinson S; Bansal GP; Mandal T; Kumar N
Pharm Res; 2015 Dec; 32(12):3827-36. PubMed ID: 26113235
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.
Datta D; Bansal GP; Gerloff DL; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2017 Jan; 35(2):264-272. PubMed ID: 27912985
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.
Tiwari S; Goyal AK; Mishra N; Khatri K; Vaidya B; Mehta A; Wu Y; Vyas SP
J Control Release; 2009 Dec; 140(2):157-65. PubMed ID: 19686788
[TBL] [Abstract][Full Text] [Related]
15. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P
Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196
[TBL] [Abstract][Full Text] [Related]
16. Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose.
Huang WC; Deng B; Mabrouk MT; Seffouh A; Ortega J; Long C; Miura K; Wu Y; Lovell JF
Malar J; 2020 Aug; 19(1):309. PubMed ID: 32859199
[TBL] [Abstract][Full Text] [Related]
17. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
Miura K; Takashima E; Deng B; Tullo G; Diouf A; Moretz SE; Nikolaeva D; Diakite M; Fairhurst RM; Fay MP; Long CA; Tsuboi T
Infect Immun; 2013 Dec; 81(12):4377-82. PubMed ID: 24042109
[TBL] [Abstract][Full Text] [Related]
18. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate.
Radtke AJ; Anderson CF; Riteau N; Rausch K; Scaria P; Kelnhofer ER; Howard RF; Sher A; Germain RN; Duffy P
Sci Rep; 2017 Jan; 7():40312. PubMed ID: 28091576
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.
Liu F; Li L; Zheng W; He Y; Wang Y; Zhu X; Tsuboi T; Cui L; Wang M; Cao Y
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
